1. Expression of CD10 and CD15 in colorectal mucinous and signet ring adenocarcinomas and its relation to clinicopathological features and prognosis
- Author
-
Ziad Emarah, Sara Waleed Hussian, Abd Al-Rahman Mohammad Foda, Hadi Abdulhadi Helali, Nadeem Ikram, Fayza Sami Fayad, Tamer Akl, Ahmed M. Ramez, Khaled Abdelwahab, and Haitham Abdulkarem Alamer
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Adenoma ,CD15 ,Adenocarcinoma ,medicine.disease_cause ,immune system diseases ,hemic and lymphatic diseases ,Internal medicine ,Genetics ,medicine ,Carcinoma ,Humans ,business.industry ,General Medicine ,Prognosis ,medicine.disease ,Adenocarcinoma, Mucinous ,Immunohistochemistry ,Clinicopathological features ,Colorectal Neoplasms ,Carcinogenesis ,business ,Carcinoma, Signet Ring Cell ,Signet ring - Abstract
BACKGROUND: CD10 and CD15 expression has been reported in several tumors. Whether CD10 and CD15 have a role in colorectal mucinous and signet ring adenocarcinoma (MSA) tumorigenesis is not yet known. OBJECTIVE: We aimed to investigate the role of CD10 and CD15 expression in mucinous colorectal adenoma-carcinoma sequence (ACS) and determine if there is any clinical and prognostic significance associated with their expression. METHODS: Seventy-five cases of colorectal MSA, and 9 cases of adenoma samples were collected. Manual TMA blocks were constructed and immunohistochemistry for CD10 and CD15 was done. RESULTS: Compared to adenomas, CD15 expression was significantly higher in MSA (p= 0.002), in contrast to CD10 expression. CD15 positivity was significantly associated with microsatellite stable (MSS) tumors (p= 0.018). The association between CD10 positivity and fungating tumor growth showed marginal significance. Unlike CD10, CD15 positivity showed significant association with overall survival of colorectal MSA patients. CONCLUSIONS: CD15 expression seems to have a role in mucinous colorectal ACS, with significant impact on the survival of MSA patients. Further studies are suggested to identify any genetic alterations that may underlie a potential association with disease progression.
- Published
- 2022
- Full Text
- View/download PDF